Cartalax 20 mg
- Active Substance: Cartalax
- Concentration: 20 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Cartalax
- Molecular Formula: C12H19N3O8
- Molecular Weight: 333.29 g/mol
- Sequence: Ala-Glu-Asp
- Synonyms: AED, T-31, SCHEMBL5324601
Cartalax 20 mg – The Architect of Tissue Vitality
Product Summary
Picture a research landscape where joints regain flexibility, tissues resist aging, and inflammation fades effortlessly. Cartalax 20 mg vial from Peptide Sciences USA, a bioregulatory tripeptide, brings this vision to life. By targeting fibroblasts, Cartalax enhances cartilage repair, promotes skin and kidney health, and combats cellular senescence, offering a prestigious tool for pioneering joint health and anti-aging research.
How Cartalax Works
Cartalax, a synthetic tripeptide with the sequence Ala-Glu-Asp, is a bioregulator that modulates fibroblast activity across tissues like cartilage, skin, and kidneys. It enhances cell proliferation by increasing Ki-67 expression, a marker of cell division, while reducing p53 signaling, a pro-apoptotic factor, thereby decreasing programmed cell death. Cartalax also upregulates CD98hc, a protein involved in amino acid transport and integrin signaling, and suppresses caspase-3 activity, further inhibiting apoptosis. These actions promote cellular vitality and extend replicative lifespan in fibroblast cultures.
In preclinical studies, Cartalax reduced inflammation in cartilage by modulating cytokine levels and preserved extracellular matrix integrity by inhibiting MMP-9 synthesis. In renal epithelial cell cultures, it increased proliferation and SIRT-6 expression, a longevity-associated protein, by 2–3x, suggesting geroprotective effects. These mechanisms make Cartalax a versatile candidate for researching osteoarthritis, skin aging, and kidney regeneration.
Why Choose Cartalax 20 mg?
Cartalax is a cornerstone for joint health and anti-aging research, offering transformative benefits. Here's why it stands out:
- Cartilage Regeneration: Stimulates chondrocyte proliferation and collagen synthesis, supporting cartilage repair in osteoarthritis models.
- Anti-Aging Effects: Increases Ki-67 and SIRT-6 expression, rejuvenating aging fibroblasts and extending tissue lifespan.
- Inflammation Reduction: Modulates cytokines and inhibits MMP-9, reducing joint and tissue inflammation by up to 40% in preclinical studies.
- Multi-Tissue Support: Enhances skin, kidney, and connective tissue health, offering broad research applications for longevity and regeneration.
- Superior Quality: Peptide Sciences USA guarantees 99% purity through advanced synthesis, ensuring reliable research outcomes.
Cartalax 20 mg empowers researchers to revolutionize joint health and anti-aging studies, backed by cutting-edge bioregulator peptide science.
Product Specifications
Peptide Sciences USA's Cartalax 20 mg vial is crafted for precision in joint and anti-aging research, delivering exceptional quality. Here's the breakdown:
- Composition: Contains 20 mg of Cartalax (C12H19N3O8, molecular weight 333.29 g/mol).
- Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous or intramuscular injection.
- Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
- Usage Guidelines: Reconstitute with bacteriostatic water and administer via subcutaneous or intramuscular injection, typically at 0.3–2 mg/day for 10–20 days in research protocols. Use under professional supervision.
- Storage: Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
- Safety: Preclinical studies report minimal side effects; limited human data requires research oversight.
This peptide is for research purposes only, providing a robust platform for studying cartilage health and longevity.
Legal Disclaimer
Cartalax 20 mg is supplied for research purposes only and is not FDA-approved for human use. It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical research.
Frequently Asked Questions
What is Cartalax?
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) bioregulator that targets fibroblasts to support cartilage, skin, and kidney health. It modulates gene expression to enhance cell proliferation and reduce senescence in research models.
What are Cartalax peptide benefits?
Cartalax promotes cartilage regeneration, reduces joint inflammation by up to 40%, rejuvenates aging fibroblasts, and supports kidney cell proliferation, making it ideal for osteoarthritis, anti-aging, and longevity research.
What are Cartalax peptide side effects?
Preclinical studies report minimal side effects, with rare instances of mild digestive upset or injection site reactions. Limited human data necessitates professional oversight for research safety.
How is Cartalax 20 mg administered in research?
Cartalax is supplied as a 20 mg lyophilized powder. Reconstitute with bacteriostatic water and administer via subcutaneous or intramuscular injection, typically at 0.3–2 mg/day for 10–20 days in research protocols, under professional guidance.
How should Cartalax 20 mg be stored?
Store the lyophilized powder at -20°C. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 30 days to maintain potency.
Related Products
- Active Substance: Epitalon
- Concentration: 50 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Epitalon
- Molecular Formula: C14H22N4O9
- Molecular Weight: 390.35 g/mol
- Sequence: Ala-Glu-Asp-Gly
- Synonyms: Epithalon, AEDG, Epithalamin analog
- Active Substance: Proxofim (FOXO4-D-Retro-Inverso)
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Proxofim
- Molecular Formula: C228H388N86O64
- Molecular Weight: 5358.05 g/mol
- Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
- Synonyms: Forkhead box protein O4 D-Retro-Inverso, FOXO4a, AFX, AFX1, MLLT7
- Active Substance: HGH Fragment 176-191 (6 mg), Modified GRF (CJC-1295 No DAC, 3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg Modified GRF + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (Modified GRF): C152H252N44O42
- Molecular Weight (Modified GRF): 3367.97 g/mol
- Sequence (Modified GRF): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), Modified GRF (CJC-1295 No DAC), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: HGH Fragment 176-191 (6 mg), CJC1295 No DAC (3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg CJC1295 + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (CJC1295 No DAC): C152H252N44O42
- Molecular Weight (CJC1295 No DAC): 3367.97 g/mol
- Sequence (CJC1295 No DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), CJC1295 No DAC (Mod GRF), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: Tripeptide-1 (Glycyl-L-Histidyl-L-Lysine)
- Concentration: 200 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: GHK Basic
- Molecular Formula: C14H24N6O4
- Molecular Weight: 340.38 g/mol
- Sequence: Gly-His-Lys
- Synonyms: GHK, Glycyl-L-Histidyl-L-Lysine, Tripeptide-1